2021

  • Tailoring wearable technology and telehealth in treating Parkinson’s disease

    August 18, 2021
    Wearable health technologies are vastly popular with people wanting to improve their physical and mental health. Everything from exercise, sleep patterns, calories consumed and heart rhythms can be tracked by a wearable device. But timely and accurate data is also especially valuable for doctors treating patients with complicated health conditions using virtual care. A new study from the Southern Medical Program (SMP), based at UBC Okanagan, has examined the use of wearable health technology and telehealth to treat patients with Parkinson’s disease.

  • Walking patterns could predict type of cognitive decline

    February 16, 2021
    A new study by a Canadian research team, led by London researchers from Western University and Lawson Health Research Institute evaluated the walking patterns and brain function of 500 participants currently enrolled in clinical trials. Their findings are published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.

  • Medical software licence underlines WORLDiscoveries success

    February 01, 2021
    Ting-Yim Lee, imaging professor at Schulich School of Medicine & Dentistry, has developed software used in CT scanners, to measure blood flow. His cutting-edge CT Perfusion technology measures blood flow in bodily tissues, helping computerized tomography scans guide treatment for patients who have had a stroke. The software is also used to get a handle on the spread of cancer in patients and to assess how well tumours have responded to treatment. Lee is also working to adapt it for patients with heart attack, pulmonary embolism or arthritis.

  • Hormone-Mimicking Compound Shows Promise in Myelin Repair

    January 14, 2021
    A compound developed at Oregon Health & Science University appears to protect nerve fibers and the fatty sheath, called myelin, that covers nerve cells in the brain and spinal cord. The discovery, published in the Journal of Neuroimmunology, could be important in treating or preventing the progression of multiple sclerosis and other central nervous system disorders. The new research in a mouse model advances earlier work to develop the compound - known as sobetirome - that has already showed promise in stimulating the repair of myelin.